Canal Capital Management’s Gilead Sciences GILD Stock Holding History

Canal Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,957	Closed	-$769K	–	116
2018 Q3	$769K	Sell	9,957 -68	-0.7%	-$5.14K	0.44%	66
2018 Q2	$710K	Buy	10,025 +295	+3%	+$20.8K	0.4%	70
2018 Q1	$734K	Sell	9,730 -1,777	-15%	-$141K	0.42%	61
2017 Q4	$824K	Buy	11,507 +2,814	+32%	+$214K	0.45%	59
2017 Q3	$704K	Sell	8,693 -441	-5%	-$33.7K	0.42%	60
2017 Q2	$646K	Buy	9,134 +1,297	+17%	+$86.3K	0.4%	59
2017 Q1	$532K	Buy	7,837 +4,235	+118%	+$298K	0.36%	63
2016 Q4	$258K	Buy	+3,602	New	+$268K	0.21%	72

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Canal Capital Management's GILD Position: Q4 2018 in Review

Canal Capital Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 9,957 shares — an estimated $769K sold.

Canal Capital Management first reported a position in GILD in Q4 2016 and held it in 8 quarters. The position peaked at $824K in Q4 2017. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Canal Capital Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
Canal Capital Management sold 9,957 Gilead Sciences shares in Q4 2018, an estimated $769K.
Canal Capital Management first reported a position in Gilead Sciences in Q4 2016 and held it in 8 quarters.
Canal Capital Management's Gilead Sciences position peaked at $824K in Q4 2017.
1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Canal Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.